Sourcing Survey 2024 - From global to regional

Sourcing Survey 2024 – From global to regional

ARC Group 2024 Sourcing Survey

Since 2013, ARC Consulting has been conducting annual sourcing surveys to assess the evolving perception of Asia as a sourcing market and to track changes over time. The 2024 survey focuses on how businesses have adapted their sourcing strategies in light of recent global challenges. This year’s findings highlight a significant shift from global to regional sourcing, reflecting a strategic response to ongoing disruptions in logistics and supply chains. The survey also explores emerging trends and provides insights into future outlooks in this dynamic landscape.

Download the 2024 Sourcing Survey (PDF, 2.57 MB)

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission